Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07879105
NA

Dorsal Penile Nerve Cryoneurolysis for Lifelong PE

Sponsor: Biruni University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial was to learn whether adding dorsal penile nerve cryoneurolysis to medication and behavioral therapy helps men with lifelong premature ejaculation. Cryoneurolysis is a treatment that uses cold to temporarily reduce nerve signals. The study also looked at the safety of this treatment. The main questions were: Does adding cryoneurolysis make the time from vaginal penetration to ejaculation longer after 3 months? Does adding cryoneurolysis improve premature ejaculation symptoms and satisfaction without worsening erectile function? What side effects occur after cryoneurolysis? Researchers compared cryoneurolysis plus medication and behavioral therapy with the same medication and behavioral therapy without cryoneurolysis. Participants: Took sertraline and tadalafil once daily for 3 months. Received education about behavioral techniques for better ejaculation control. Were randomly assigned either to receive one cryoneurolysis procedure or to receive no cryoneurolysis procedure. Used a stopwatch to record the time from vaginal penetration to ejaculation and completed questionnaires during follow-up.

Official title: Percutaneous Dorsal Penile Nerve Cryoneurolysis as an Adjunct to Combined Pharmacological and Behavioural Therapy for Lifelong Premature Ejaculation: A Single-Centre Randomized Controlled Study

Key Details

Gender

MALE

Age Range

25 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

117

Start Date

2026-02-04

Completion Date

2026-05-25

Last Updated

2026-10-16

Healthy Volunteers

No

Interventions

PROCEDURE

Percutaneous Dorsal Penile Nerve Cryoneurolysis

A single percutaneous dorsal penile nerve cryoneurolysis procedure was performed under sterile conditions using a CRYO-S® Painless cryoanalgesia system with a 21-gauge, 0.8-mm cryoprobe. Four dorsal treatment targets were accessed through one dorsal coronal puncture site. Each target received two 2-minute freezing cycles at approximately -78°C, separated by a 15-second thaw period.

DRUG

Sertraline (Oral Antidepressant)

Sertraline 50 mg was taken orally once daily for 3 months.

DRUG

Tadalafil 5 mg

Tadalafil 5 mg was taken orally once daily for 3 months.

BEHAVIORAL

Behavioral Education for Ejaculatory Control

Participants received one individual educational session addressing premature ejaculation and ejaculatory control. The session included recognition of rising arousal and pre-ejaculatory sensations, the stop-start technique, and the squeeze technique as an alternative. Participants were instructed to practice these strategies at home and during sexual activity.

Locations (1)

Biruni University Faculty of Medicine Hospital

Istanbul, Küçükçekmece, Turkey (Türkiye)